A detailed history of D. E. Shaw & Co., Inc. transactions in Baxter International Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 80,000 shares of BAX stock, worth $2.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80,000
Holding current value
$2.64 Million
% of portfolio
0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$32.85 - $40.26 $2.71 Million - $3.33 Million
-82,621 Reduced 82.37%
17,686 $671,000
Q2 2024

Aug 14, 2024

BUY
$32.87 - $43.55 $3.3 Million - $4.37 Million
100,307 New
100,307 $3.36 Million
Q4 2023

Feb 14, 2024

SELL
$31.71 - $38.95 $18.5 Million - $22.8 Million
-584,377 Reduced 76.22%
182,351 $7.05 Million
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $39 Million - $51.5 Million
-1,045,842 Reduced 57.7%
766,728 $28.9 Million
Q2 2023

Aug 14, 2023

SELL
$39.98 - $47.68 $47.7 Million - $56.9 Million
-1,193,668 Reduced 39.71%
1,812,570 $82.6 Million
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $70.9 Million - $99.2 Million
1,886,914 Added 168.58%
3,006,238 $122 Million
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $44.9 Million - $52.1 Million
903,291 Added 418.13%
1,119,324 $57.1 Million
Q3 2022

Nov 14, 2022

SELL
$53.86 - $66.8 $2.21 Million - $2.74 Million
-41,065 Reduced 15.97%
216,033 $11.6 Million
Q2 2022

Aug 15, 2022

SELL
$63.83 - $80.0 $33.6 Million - $42.1 Million
-526,744 Reduced 67.2%
257,098 $16.5 Million
Q1 2022

May 16, 2022

SELL
$76.85 - $89.45 $61.2 Million - $71.3 Million
-796,986 Reduced 50.42%
783,842 $60.8 Million
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $58.9 Million - $68.9 Million
-790,483 Reduced 33.34%
1,580,828 $136 Million
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $10.7 Million - $12.1 Million
144,980 Added 6.51%
2,371,311 $191 Million
Q2 2021

Aug 16, 2021

SELL
$80.5 - $88.01 $63.4 Million - $69.3 Million
-787,888 Reduced 26.14%
2,226,331 $179 Million
Q1 2021

May 17, 2021

SELL
$76.38 - $86.03 $74.4 Million - $83.8 Million
-974,013 Reduced 24.42%
3,014,219 $254 Million
Q4 2020

Feb 16, 2021

BUY
$75.39 - $82.36 $94.8 Million - $104 Million
1,257,502 Added 46.05%
3,988,232 $320 Million
Q3 2020

Nov 16, 2020

BUY
$78.33 - $90.73 $123 Million - $142 Million
1,570,024 Added 135.26%
2,730,730 $220 Million
Q2 2020

Aug 14, 2020

BUY
$78.66 - $94.14 $76.4 Million - $91.4 Million
970,967 Added 511.74%
1,160,706 $99.9 Million
Q1 2020

May 15, 2020

BUY
$71.57 - $93.3 $4.71 Million - $6.13 Million
65,752 Added 53.03%
189,739 $15.4 Million
Q4 2019

Feb 14, 2020

BUY
$76.7 - $88.45 $8.38 Million - $9.66 Million
109,225 Added 739.91%
123,987 $10.4 Million
Q3 2019

Nov 14, 2019

SELL
$81.4 - $89.78 $1.32 Million - $1.46 Million
-16,275 Reduced 52.44%
14,762 $1.29 Million
Q2 2019

Aug 14, 2019

SELL
$73.44 - $82.41 $12.8 Million - $14.3 Million
-174,042 Reduced 84.87%
31,037 $2.54 Million
Q1 2019

May 15, 2019

SELL
$64.48 - $81.31 $8.57 Million - $10.8 Million
-132,950 Reduced 39.33%
205,079 $16.7 Million
Q4 2018

Feb 14, 2019

SELL
$61.45 - $77.8 $7.64 Million - $9.67 Million
-124,308 Reduced 26.89%
338,029 $22.2 Million
Q3 2018

Nov 14, 2018

SELL
$70.71 - $77.75 $1.55 Million - $1.71 Million
-21,982 Reduced 4.54%
462,337 $35.6 Million
Q2 2018

Aug 14, 2018

SELL
$63.43 - $75.41 $37.5 Million - $44.6 Million
-591,086 Reduced 54.96%
484,319 $35.8 Million
Q1 2018

May 15, 2018

BUY
$62.56 - $72.26 $35.4 Million - $40.9 Million
565,966 Added 111.1%
1,075,405 $69.9 Million
Q4 2017

Feb 14, 2018

BUY
$61.45 - $66.05 $13.2 Million - $14.2 Million
215,508 Added 73.32%
509,439 $32.9 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $17.5 Million - $19 Million
293,931
293,931 $18.4 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.